• Tesla expects vehicle delivery growth to average 50% for multi-years. While sales in the US seemed to have stagnated in the past three years, we believe recent price cuts for Model Y may have improved Tesla’s competitive positioning vis-à-vis peers in the U.S.
• Tesla reiterated that the idea behind making its own cells is to help it tackle shortfalls in cell output, not disintermediate its cell suppliers. Instead, it is urging its suppliers to increase production. This points to expectations of strong demand.
• Operating margin was 5.4% in 4Q20, with increased expenses in R&D. Tesla expects margins to expand in the next few quarters. Consensus for Tesla’s operating margins are 8.5% in 1Q21 and 9.5% in 2Q21.
• We expect revenue to accelerate in 2021 with its capacity ramp-up and a potential easing of its battery-cell constraints. We have a TECHNICAL BUY rating for TSLA with buy limit at US$872.79.

3 Takeaways from 4Q20 Earnings

1. Strong growth in deliveries; momentum to continue. 4Q20 vehicle deliveries grew 61% YoY, beating their 44% growth rate in 3Q (Figure 1). This was mainly contributed by rising Model 3 and Y deliveries, which accounted for 90% of overall deliveries.

Tesla expects vehicle delivery growth to average 50% for multi-years. It expects to “materially exceed this (growth rate) in 2021”. This flags a strong pick-up in deliveries from FY20’s +35.8%. We think Tesla may be able to attain its target, with its new Model 3 upgrades and rollout of Model Y to overseas markets.

While sales in the US seemed to have stagnated in the past three years (Figure 2), recent price cuts for Model Y may have improved Tesla’s competitive positioning vis-à-vis peers in the U.S (Figure 3). Tesla has also started to deliver Model Y in China, its second-largest market. Its pricing is on par with competitors such as Nio ES6 and BMW’s X3.

2. Robust pipeline of products and new factories. Tesla expects its factories, Giga Berlin and Giga Texas, to start production of Model Y later this year. Volume production should skew towards 2H21. Its Shanghai factory started producing Model Y in late 2020 and is in the process of ramping to full capacity.

A battery-cell factory is also being constructed in the Bay Area. This will reinforce its shift to in-house cell production. Tesla reiterated that the idea behind making its own cells is to help it tackle shortfalls in cell output, not disintermediate its cell suppliers such as CATL, Panasonic and LG. Instead, it is urging its suppliers to increase production and “we (Tesla) will take as many batteries as they can produce”. This points to expectations of strong demand.

Volume production of its Cybertruck is expected to be in 2022. Tesla Semi’s production is restricted by a short supply of battery cells as resources have been prioritised for cars with better margins. This again boils down to its current problem of a shortage of battery cells as global demand continues to outpace production. We believe that once supply improves, Tesla will be able to ramp up production to meet growing demand.

3. Improvements in financials expected. Operating margin was 5.4% in 4Q20, with increased expenses in R&D. Tesla expects margins to expand and remain ‘industry-leading’ in the next few quarters. In the North America region, operating margins for automobile players averaged to be around 6% as of 4Q20. Bloomberg consensus for Tesla’s operating margins are 8.5% in 1Q21 and 9.5% in 2Q21 (Figure 4).

FCF was US$2.06bn. Management will be focusing on debt reduction. In the latest quarter, it made an early settlement of US$2bn in convertible notes. With that, debt-to-EBIT improved to 5.9x from 20.5x in 1Q20.

With improved liquidity, Tesla can turn its attention to expanding production capacity and investing in infrastructure such as a supercharging network to “get ahead of demand”.

Round-up

We are positive on Tesla. We expect revenue to accelerate in 2021 with its capacity ramp-up and a potential easing of its battery-cell constraints. According to the International Energy Agency, electric cars accounted for only 1% of the global car stock in 2019. Tesla’s share of automobile sales in the US has climbed in recent years, from 0.03% to 2013 to 1.31% in 2019 (Figure 5). We see headroom for further expansion, as the adoption of electric cars is expected to receive a timely boost from the Biden administration’s green drive and policy initiatives from the European Green Deal.

Technical analysis

Tesla Inc (US: TSLA) had a strong run-up to US$900.40 in January, which broke the top of the pennant resistance (see our report dated 25 January 2021). However, its rally lost steam and its price quickly retreated to the US$780 region before rebounding on 1 February. Technicals indicate that Tesla is looking to complete the last leg of the sub-wave v of its extended wave (iii):

1. Tesla’s uptrend is intact despite its recent correction. Tesla has been making a series of higher highs and lows, with prices trending above both its 50- and 200-day moving averages. The stock’s mean distance is still far from its current price to 50-day MA, which suggests it remains in a strong bullish uptrend.
2. Elliott wave count remains the same as what we observed on 25 January 2021. The only difference is, its sub-corrective wave iv has evolved into an expanded flat from the pennant.
3. Tesla’s bullish candle on Monday opened and closed higher than its bearish candle last Friday, after its bearish candle touched base at the 123.6% extension level of wave (a)(b).

*Timeline of the trade is eight weeks from date issued.

CHART LEGENDS

Moving averages

Red dotted line = 200 Periods MA

Blue dotted line = 50 Periods MA

 

Disclaimer
Important Information: This report is prepared and/or distributed by Phillip Securities Research Pte Ltd (“Phillip Securities Research”), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.
By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.
The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.
Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.
This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgement. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.
Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.
Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.
Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.
To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.
The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.
This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.
This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.
IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSES Where the report contains research analyses or reports from a foreign research house, please note: (i) recipients of the analyses or reports are to contact Phillip Securities Research (and not the relevant foreign research house) in Singapore at 250 North Bridge Road, #06-00 Raffles City Tower, Singapore 179101, telephone number +65 6533 6001, in respect of any matters arising from, or in connection with, the analyses or reports; and (ii) to the extent that the analyses or reports are delivered to and intended to be received by any person in Singapore who is not an accredited investor, expert investor or institutional investor, Phillip Securities Research accepts legal responsibility for the contents of the analyses or reports.

If Distribution is to Australian Investors This report is produced by Phillip Securities Pte Ltd and is being distributed in Australia by Phillip Capital Limited (Australian Financial Services License No. 246827). This report contains general securities advice and does not take into account your personal objectives, situation and needs. Past performance is not a reliable indicator of future performance. Please read the Disclosures and Disclaimers set out above. By receiving or reading this report, you agree to be bound by the terms and limitations set out above. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.